Last reviewed · How we verify

NCT07513844

Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease

Not yet recruiting NA Last updated 13 April 2026
What this trial tests

NA trial testing Low-Intensity Focused Ultrasound Stimulation(LIFU) in Huntington Disease in 24 participants. Not yet recruiting.

Timeline
31 March 2026
Primary endpoint
31 October 2026
31 March 2027

Quick facts

Lead sponsorFirst Affiliated Hospital of Fujian Medical University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingsingle
Primary purposetreatment
Enrollment24
Start date31 March 2026
Primary completion31 October 2026
Estimated completion31 March 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

First Affiliated Hospital of Fujian Medical University

Who can join

Adults 18 to 75, any sex, with Huntington Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to determine the optimal pulse repetition frequency of low-intensity focused ultrasound that is safe and effective in improving motor symptoms in patients with Huntington's disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Huntington Disease

Currently open trials in the same condition.

Other First Affiliated Hospital of Fujian Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07513844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing